Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.26
DYNT's Cash to Debt is ranked lower than
85% of the 322 Companies
in the Global Medical Devices industry.

( Industry Median: 2.16 vs. DYNT: 0.26 )
Ranked among companies with meaningful Cash to Debt only.
DYNT' s Cash to Debt Range Over the Past 10 Years
Min: 0.01  Med: 0.07 Max: 0.62
Current: 0.26
0.01
0.62
Equity to Asset 0.43
DYNT's Equity to Asset is ranked lower than
76% of the 292 Companies
in the Global Medical Devices industry.

( Industry Median: 0.63 vs. DYNT: 0.43 )
Ranked among companies with meaningful Equity to Asset only.
DYNT' s Equity to Asset Range Over the Past 10 Years
Min: 0.32  Med: 0.5 Max: 0.71
Current: 0.43
0.32
0.71
F-Score: 3
Z-Score: 2.31
M-Score: -3.04
WACC vs ROIC
3.98%
-21.86%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) -4.35
DYNT's Operating margin (%) is ranked lower than
58% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 2.69 vs. DYNT: -4.35 )
Ranked among companies with meaningful Operating margin (%) only.
DYNT' s Operating margin (%) Range Over the Past 10 Years
Min: -28.6  Med: 0.22 Max: 3.3
Current: -4.35
-28.6
3.3
Net-margin (%) -8.97
DYNT's Net-margin (%) is ranked lower than
62% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 1.18 vs. DYNT: -8.97 )
Ranked among companies with meaningful Net-margin (%) only.
DYNT' s Net-margin (%) Range Over the Past 10 Years
Min: -25.91  Med: -0.12 Max: 1.29
Current: -8.97
-25.91
1.29
ROE (%) -85.84
DYNT's ROE (%) is ranked lower than
86% of the 298 Companies
in the Global Medical Devices industry.

( Industry Median: 1.21 vs. DYNT: -85.84 )
Ranked among companies with meaningful ROE (%) only.
DYNT' s ROE (%) Range Over the Past 10 Years
Min: -97.41  Med: -0.54 Max: 6.42
Current: -85.84
-97.41
6.42
ROA (%) -15.61
DYNT's ROA (%) is ranked lower than
64% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: 0.05 vs. DYNT: -15.61 )
Ranked among companies with meaningful ROA (%) only.
DYNT' s ROA (%) Range Over the Past 10 Years
Min: -45.65  Med: -0.23 Max: 2.64
Current: -15.61
-45.65
2.64
ROC (Joel Greenblatt) (%) -11.52
DYNT's ROC (Joel Greenblatt) (%) is ranked lower than
56% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: 4.17 vs. DYNT: -11.52 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
DYNT' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -75.98  Med: 0.94 Max: 9.6
Current: -11.52
-75.98
9.6
Revenue Growth (3Y)(%) -2.20
DYNT's Revenue Growth (3Y)(%) is ranked lower than
69% of the 233 Companies
in the Global Medical Devices industry.

( Industry Median: 4.10 vs. DYNT: -2.20 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
DYNT' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -3.8  Med: 3.3 Max: 37.6
Current: -2.2
-3.8
37.6
EPS Growth (3Y)(%) 508.40
DYNT's EPS Growth (3Y)(%) is ranked higher than
99% of the 196 Companies
in the Global Medical Devices industry.

( Industry Median: 2.70 vs. DYNT: 508.40 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
DYNT' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -61.5  Med: -11.2 Max: 508.4
Current: 508.4
-61.5
508.4
» DYNT's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-09-28)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Insider Trades

Latest Guru Trades with DYNT

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices
Compare:OTCPK:GIDYL, OTCPK:ZYXI, OTCPK:AIRW, OTCPK:ACXA, NAS:PHMD, OTCPK:SMLR, OTCPK:AROSF, NAS:MDGS, OTCPK:PETV, NAS:ESMC, OTCPK:ECGI, OTCPK:ACAR, NAS:AHPI, OTCPK:PBIO, OTCPK:ABMT, OTCPK:VYCO, NAS:ETRM, OTCPK:EQUR, AMEX:NSPR, OTCPK:NIMU » details
Dynatronics Corp manufactures & distributes physical medicine products. It offers one-stop shop for medical equipment & supplies needs, including electrotherapy & ultrasound therapy, phototherapy, & medical supplies, treatment tables, & exercise products.

Dynatronics Corp is a Utah corporation formed on April 29, 1983. The Company manufactures and distributes medical equipment including therapy devices, medical supplies and soft goods, treatment tables and rehabilitation equipment. Its products are used mainly by physical therapists, chiropractors, sports medicine practitioners, podiatrists, physicians and other physical medicine professionals. The products it manufactures falls into two categories: Physical Medicine Products and Aesthetic Products. Its Physical Medicine Products include: Electrotherapy, Therapeutic Ultrasound, Phototherapy, Thermal Therapy, Oscillation Therapy, Iontophoresis, Manufactured Medical Supplies and Soft Goods, and Manufactured Treatment Tables and Rehabilitation Equipment. The Company manufactures and markets aesthetic products under the brand name of Synergie. The Synergie Elite Aesthetic Massage System applies therapeutic vacuum massage to skin and subcutaneous tissues to achieve a temporary reduction in the appearance of cellulite and reduces the circumferential body measurements of the treated areas. It also manufactures and markets the Synergie Elite microdermabrasion device as a companion to the AMS device. The icrodermabrasion device gently exfoliates the upper layers of skin, exposing softer, smoother skin. In conjunction with the microdermabrasion devices, it offers a line of skin care products under the trademark Calisse which is designed to enhance the effects of the icrodermabrasion treatments. As part of the aesthetics line of products, it markets the Synergie Elite LT device which provides phototherapy for aesthetic pplications. Phototherapy is used in aesthetic applications to improve skin tone and appearance. Combining elements of the AMS vacuum massage techniques with microdermabrasion and Synergie Elite LT for phototherapy has provided aestheticians with the ability to provide an enhanced 'ultimate facial' available only with the use of Synergie devices. The Company's trademarks include 'Dynatron', 'Dynatron Solaris,' 'Synergie,' 'Synergie Peel,' 'Dynaheat,' 'BodyIce, and 'Nutura'. The Company sells its products mainly to licensed practitioners such as physical therapists, chiropractors, podiatrists, sports medicine specialists, medical doctors, hospitals and clinics, plastic surgeons, dermatologists and aestheticians. It has 52 direct sales representatives. Its competitors that manufactures clinical electrotherapy and ultrasound equipment include DJO (Chattanooga Brand), Rich-Mar, Mettler Electronics and the Metron Division of Patterson Medical. Its competitors in the iontophoresis market include DJO (EMPI and Iomed divisions) Rich-Mar, Travanti Pharma and ActivaTek Inc. The Company's main competition in the treatment table market is from domestic manufacturers including Hill Laboratories Company, Hausmann Industries, Patterson Medical, Bailey Manufacturing, Tri-W-G, DJO, Armedica, and Clinton Industries. Its competitor in the therap

Ratios

vs
industry
vs
history
P/B 1.95
DYNT's P/B is ranked higher than
66% of the 289 Companies
in the Global Medical Devices industry.

( Industry Median: 2.99 vs. DYNT: 1.95 )
Ranked among companies with meaningful P/B only.
DYNT' s P/B Range Over the Past 10 Years
Min: 0.54  Med: 1.42 Max: 3.76
Current: 1.95
0.54
3.76
P/S 0.22
DYNT's P/S is ranked higher than
98% of the 285 Companies
in the Global Medical Devices industry.

( Industry Median: 3.07 vs. DYNT: 0.22 )
Ranked among companies with meaningful P/S only.
DYNT' s P/S Range Over the Past 10 Years
Min: 0.11  Med: 0.31 Max: 0.83
Current: 0.22
0.11
0.83
EV-to-EBIT -10.19
DYNT's EV-to-EBIT is ranked lower than
99.99% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 21.78 vs. DYNT: -10.19 )
Ranked among companies with meaningful EV-to-EBIT only.
DYNT' s EV-to-EBIT Range Over the Past 10 Years
Min: -277.1  Med: 15 Max: 569.4
Current: -10.19
-277.1
569.4
EV-to-EBITDA -12.43
DYNT's EV-to-EBITDA is ranked lower than
99.99% of the 173 Companies
in the Global Medical Devices industry.

( Industry Median: 16.76 vs. DYNT: -12.43 )
Ranked among companies with meaningful EV-to-EBITDA only.
DYNT' s EV-to-EBITDA Range Over the Past 10 Years
Min: -68.9  Med: 14.8 Max: 226.4
Current: -12.43
-68.9
226.4
Current Ratio 3.40
DYNT's Current Ratio is ranked higher than
65% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: 2.55 vs. DYNT: 3.40 )
Ranked among companies with meaningful Current Ratio only.
DYNT' s Current Ratio Range Over the Past 10 Years
Min: 1.43  Med: 2.21 Max: 5.31
Current: 3.4
1.43
5.31
Quick Ratio 1.59
DYNT's Quick Ratio is ranked lower than
59% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: 1.94 vs. DYNT: 1.59 )
Ranked among companies with meaningful Quick Ratio only.
DYNT' s Quick Ratio Range Over the Past 10 Years
Min: 0.59  Med: 1.09 Max: 2.79
Current: 1.59
0.59
2.79
Days Inventory 98.45
DYNT's Days Inventory is ranked higher than
67% of the 281 Companies
in the Global Medical Devices industry.

( Industry Median: 132.94 vs. DYNT: 98.45 )
Ranked among companies with meaningful Days Inventory only.
DYNT' s Days Inventory Range Over the Past 10 Years
Min: 98.45  Med: 111.32 Max: 172.01
Current: 98.45
98.45
172.01
Days Sales Outstanding 40.35
DYNT's Days Sales Outstanding is ranked higher than
85% of the 269 Companies
in the Global Medical Devices industry.

( Industry Median: 68.07 vs. DYNT: 40.35 )
Ranked among companies with meaningful Days Sales Outstanding only.
DYNT' s Days Sales Outstanding Range Over the Past 10 Years
Min: 40.12  Med: 42.18 Max: 76.88
Current: 40.35
40.12
76.88
Days Payable 32.55
DYNT's Days Payable is ranked lower than
77% of the 258 Companies
in the Global Medical Devices industry.

( Industry Median: 57.81 vs. DYNT: 32.55 )
Ranked among companies with meaningful Days Payable only.
DYNT' s Days Payable Range Over the Past 10 Years
Min: 17.71  Med: 39.94 Max: 54.44
Current: 32.55
17.71
54.44

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -1.30
DYNT's 3-Year Average Share Buyback Ratio is ranked higher than
62% of the 213 Companies
in the Global Medical Devices industry.

( Industry Median: -3.40 vs. DYNT: -1.30 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
DYNT' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -15.2  Med: -0.6 Max: 2.5
Current: -1.3
-15.2
2.5

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 2.04
DYNT's Price/Tangible Book is ranked higher than
75% of the 262 Companies
in the Global Medical Devices industry.

( Industry Median: 4.38 vs. DYNT: 2.04 )
Ranked among companies with meaningful Price/Tangible Book only.
DYNT' s Price/Tangible Book Range Over the Past 10 Years
Min: 0.75  Med: 1.72 Max: 6.4
Current: 2.04
0.75
6.4
Price/Projected FCF 0.97
DYNT's Price/Projected FCF is ranked higher than
83% of the 123 Companies
in the Global Medical Devices industry.

( Industry Median: 2.10 vs. DYNT: 0.97 )
Ranked among companies with meaningful Price/Projected FCF only.
DYNT' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.58  Med: 1.34 Max: 13.15
Current: 0.97
0.58
13.15
Price/Median PS Value 0.71
DYNT's Price/Median PS Value is ranked higher than
73% of the 256 Companies
in the Global Medical Devices industry.

( Industry Median: 1.04 vs. DYNT: 0.71 )
Ranked among companies with meaningful Price/Median PS Value only.
DYNT' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.42  Med: 1.7 Max: 7.85
Current: 0.71
0.42
7.85
Earnings Yield (Greenblatt) (%) -9.80
DYNT's Earnings Yield (Greenblatt) (%) is ranked lower than
72% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 0.70 vs. DYNT: -9.80 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
DYNT' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: -9.8  Med: 3.2 Max: 7.7
Current: -9.8
-9.8
7.7
Forward Rate of Return (Yacktman) (%) -21.25
DYNT's Forward Rate of Return (Yacktman) (%) is ranked lower than
95% of the 118 Companies
in the Global Medical Devices industry.

( Industry Median: 7.76 vs. DYNT: -21.25 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
DYNT' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -23.7  Med: -1.5 Max: 16.5
Current: -21.25
-23.7
16.5

More Statistics

Revenue (TTM) (Mil) $30.19
EPS (TTM) $ -2.28
Beta0.02
Short Percentage of Float0.08%
52-Week Range $2.40 - 3.36
Shares Outstanding (Mil)2.77
» More Articles for DYNT

Headlines

Articles On GuruFocus.com
Dynatronics Corp. Reports Operating Results (10-Q) Nov 12 2010 
Dynatronics Corp. Reports Operating Results (10-Q) May 17 2010 
Dynatronics Corp. Reports Operating Results (10-Q) Feb 01 2010 
Dynatronics Corp. Reports Operating Results (10-Q/A) Aug 27 2009 
Dynatronics Corp. Reports Operating Results (10-K/A) Aug 27 2009 
Dynatronics Corp. Reports Operating Results (10-Q/A) Aug 26 2009 
Dynatronics Corp. Reports Operating Results (10-Q/A) Aug 26 2009 
Dynatronics Corp. Reports Operating Results (10-Q) May 14 2009 
Dynatronics Corp. Reports Operating Results (10-Q) Feb 14 2009 

More From Other Websites
Dynatronics Schedules Fourth Quarter and Full Year Financial Results Conference Call Sep 23 2016
Dynatronics Releases Stand Alone Ultrasound Device Sep 20 2016
Dynatronics Releases its Latest Stand Alone Ultrasound, the Dynatron® 125B Sep 20 2016
Dynatronics to Participate in Ladenburg Thalmann's Healthcare Conference Sep 16 2016
DYNATRONICS CORP Files SEC form 8-K/A, Changes in Registrant's Certifying Accountant, Financial... Jul 21 2016
DYNATRONICS CORP Files SEC form 8-K, Changes in Registrant's Certifying Accountant Jul 08 2016
Dynatronics Announces Sales Team Expansion May 26 2016
DYNATRONICS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Other Events,... May 26 2016
Dynatronics Strengthens Its Sales Management Team May 26 2016
Dynatronics Announces Transition in Executive Management May 23 2016
Dynatronics Announces Transition in Executive Management May 23 2016
DYNATRONICS CORP Financials May 21 2016
Dynatronics Corp. :DYNT-US: Earnings Analysis: Q3, 2016 By the Numbers May 19 2016
DYNATRONICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 17 2016
Dynatronics Announces Fiscal 2016 Third Quarter Results May 16 2016
DYNATRONICS CORP Files SEC form 10-Q, Quarterly Report May 16 2016
Dynatronics Announces Fiscal 2016 Third Quarter Financial Results May 16 2016
Dynatronics to Announce Fiscal 2016 Third Quarter Results May 03 2016
Dynatronics To Release Fiscal Third Quarter Results Monday, May 16, 2016; Conference Call set for... May 03 2016
Dynatronics Congratulates UConn Huskies - The 2016 Women's Champions Apr 06 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)